Illumina, Inc. (NASDAQ:ILMN) today announced that it has begun shipping its new HumanOmni2.5-Quad DNA Analysis BeadChip (Omni2.5). This microarray contains millions of newly discovered genome-wide ...
Illumina began taking orders for a new whole-genome expression product for rat that analyzes 12 samples in parallel on a single BeadChip. Content for the new RatRef-12 Expression BeadChip is derived ...
For most researchers DNA microarrays are synonymous with high-throughput gene expression analysis. But they also are invaluable genotyping tools. Now that the International HapMap Project (see article ...
Illumina, Inc. (NASDAQ:ILMN) today announced the HumanOmniExpress BeadChip (OmniExpress), the newest addition to the Omni family of microarrays for genome-wide association studies (GWAS). Designed as ...
Illumina, Inc. has announced that it is collaborating with the Wellcome Trust Sanger Institute (WTSI) and the Wellcome Trust Case-Control Consortium (WT-CCC) on the design of a custom Sentrix® ...
Microarray-based transcription profiling studies have provided important advances in our understanding of differential gene expression in heterogeneous cell populations—for example, in cancerous ...
DUBLIN--(BUSINESS WIRE)--The "2018 Global Immunohematology and Infectious Disease NAT Screening: Market Shares by Country, Emerging Technologies, Strategic Profiles of Leading Suppliers" report has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback